Ahmed Aloraij is a distinguished leader and visionary in the global health tourism sector, recognized for his pioneering contributions to advancing Saudi Arabia’s role as a premier destination for health and wellness travel. With more than two decades of expertise spanning healthcare, tourism, and investment, he has been instrumental in shaping the Kingdom’s medical tourism landscape and positioning it on the international stage. He currently serves as Chairman of the Saudi Health Tourism Association, where he leads national efforts to align healthcare and tourism sectors with Saudi Arabia’s Vision 2030 goals. In addition, he holds the position of Vice President of the Global Healthcare Travel Council (GHTC), representing Saudi Arabia in global dialogues on cross-border healthcare collaboration and patient mobility. Mr. Aloraij is the founder of the Health Tourism Future Forum (HTF), an international conference that convenes leaders, policymakers, and innovators to foster dialogue and partnerships in the medical tourism industry. He is also the CEO of BLSM, Saudi Arabia’s first AI-powered medical coordination platform, which connects patients with accredited providers while integrating concierge services and advanced digital healthcare solutions. Through his leadership, Mr. Aloraij has championed initiatives that strengthen international cooperation, enhance service quality, and expand access to world-class medical care. His vision reflects a commitment to building bridges between nations, providers, and patients, ensuring that Saudi Arabia plays a central role in shaping the future of global medical tourism.

From balancing balance sheets to tipping the scales of gender balance and healthcare equity, a Chartered Accountant turned Social Entrepreneur, Alisha Moopen is at the forefront of Transforming the Journey from Illness to Wellness for millions of people across the globe. Currently serving as the Managing Director and Group CEO of Aster DM Healthcare, Alisha is building a sustainable future for the organization and the 38-year-old legacy built by her father, Padmashree Dr. Azad Moopen, whose vision to make quality healthcare accessible helped Aster reach tens of millions of patients over the years. Alisha was elected by the World Economic Forum as a Young Global Leader to join the class of 2018 and she was the first female Chapter Chair of YPO’s Dubai Chapter. She is the Founder and Vice-Chairwoman of Dubai Healthcare Business Group.

Eng. Marwan bin Salama Albalawi serves as the Head of Digital Health at Lean and possesses over 15 years of experience in digital health, information technology, performance management, and data analysis.

Throughout his career, Eng. Marwan has contributed to the development of digital solutions and enhanced performance efficiency in prominent healthcare institutions such as Prince Mohammed bin Abdulaziz Medical City, King Fahad Medical City, and Lean Business Services. His extensive expertise in leveraging modern technologies and data analysis has supported the digital transformation of the healthcare sector.

Eng. Marwan holds a Master’s degree in Leadership from Oxford University, a Master’s in Informatics from Leeds University, and a Bachelor’s degree in Software Engineering from King Fahd University of Petroleum and Minerals.

Sameh Rakha is the Medical Director for Boehringer Ingelheim for Saudi Arabia, Gulf, and East Africa, leading efforts to foster collaborative scientific innovation, research and patient care across key therapeutic areas. With 20+ years in pharma, Sameh has extensive experience in Clinical development, medical affairs and pharmacovigilance leadership roles. He has a strong track record of expanding clinical trial footprint in countries within our region. Sameh is a medical doctor started his career as a urologist. He began his pharma career in 2004, working across Egypt, GCC countries and Switzerland. He also holds a diploma in health economics.

Professor Peter Goadsby is one of the world’s leading neurologists and neuroscientists, widely recognized for his pioneering research into the mechanisms of migraine and cluster headache. His work has fundamentally advanced the understanding, diagnosis, and treatment of primary headache disorders, directly influencing clinical practice and improving patient outcomes worldwide. At KAUST, Professor Goadsby serves as Senior Associate to the President, where he contributes to strengthening the University’s role in advancing translational research and building collaborations that extend from laboratory discovery to healthcare systems in Saudi Arabia and beyond. His appointment underscores the Kingdom’s growing international stature in science, medicine, and innovation.

Abdul Qayyum has been the General Manager of Roche Diagnostics in Saudi Arabia since November 2024, overseeing a team of 175 professionals. Before this position, he was the Country Manager for Roche Diagnostics, Pakistan and Afghanistan. With 29 years of committed service and expertise at Roche, Abdul Qayyum is an accomplished leader recognized for his exceptional capacity to drive growth and achieve organizational success. Throughout his nearly three-decade career, he has assumed various roles with increasing levels of responsibility, encompassing key positions in sales, customer support, product management, business unit leadership, and marketing. His leadership and dedication have significantly contributed to the organization's success and the development of future leaders.

Bilal Muhsin serves as Executive Vice President and President of BD’s Connected Care segment. He serves as a member of the BD Executive Leadership Team.

In his role, Muhsin is responsible for leading the strategy development for BD Connected Care which aims to leverage advanced analytics and AI solutions alongside BD’s industry-leading smart devices to improve the efficiency and effectiveness of patient care while driving compelling growth opportunities in new areas of health care, such as connected medication management, advanced workflow robotics and smart monitoring solutions. Muhsin is responsible for advancing BD’s Connected Care strategy, including shaping organizational capabilities, driving and executing the commercial strategy, accelerating industry-leading innovation initiatives, and ensuring operational and quality excellence.

Muhsin joined BD from Masimo, a health technology and consumer electronics manufacturer, where he spent 25 years, most recently as Chief Operating Officer. Prior to that, he held several other leadership roles at Masimo, including Executive Vice President of engineering, marketing and regulatory. Muhsin has decades of experience with a proven track record in medical engineering and software development, and holds more than 50 patents in Medical Systems Communication, Analytics and Patient Monitoring Systems.

Muhsin holds a Bachelor of Science degree in Computer Science from San Diego State University.

Mohamed is the VP General Manager of Amgen in the Middle East & Africa (MEA), with over two
decades of experience in the Pharmaceutical and Biotech fields in various leadership roles in
strategic planning, business development and general management across Europe, Middle East &
Africa.
Additionally, he serves as the chairman of the pharmaceutical industry association in MEA
(PHARMEA). The association contributes significantly to the industry-government dialogue and
policy making in the region enhancing patient access to innovative medicines. Mohamed's
dedication to healthcare is motivated by a commitment to support patients during their most
challenging times.
He is a pharmacist, holds an MBA from Bradford University- UK, and a Six Sigma Black Belt. He is
also a member of the board of several companies in healthcare and technology startup sectors.

Alia Abdel-Razeq, the Chief Operating Officer at CellSave Arabia, stands as a prominent figurehead in the forefront of the stem cell and regenerative medicine revolution in the Middle East. She has a background rooted in chemical and pharmaceutical engineering, complemented by extensive experience in healthcare management and research. Under Alia’s insightful leadership, CellSave Arabia has expanded its offerings to cater comprehensively to the diverse needs of individuals and institutions. Notably, a groundbreaking addition is newborn stem cell storage for longevity purposes, empowering families with future-use options with stem cells and stem cell-derived exosomes. Furthermore, CellSave Arabia is pioneering stem cell therapy services, revolutionizing treatments for conditions such as autoimmune disorders, heart disease, neurological ailments, regenerative medicine, and more.